Document is current
Any future updates will be listed below
-
Authors
Okamura, Akihiko
Watanabe, Masayuki
Okui, Jun
Matsuda, Satoru
Takemura, Ryo
Kawakubo, Hirofumi
Takeuchi, Hiroya
Muto, Manabu
Kakeji, Yoshihiro
Kitagawa, Yuko
Doki, Yuichiro
- License Information
-
More Information
Article History
First Online: 5 January 2023
Disclosure
: Yuko Kitagawa; Relevant Financial Activities Outside the Submitted Work: Chugai Pharmaceutical Co., Ltd.; Taiho Pharmaceutical Co., Ltd; Yakult Honsha Co. Ltd.; Asahi Kasei Pharma Corporation; Otsuka Pharmaceutical Co., Ltd.; Takeda Pharmaceutical Co., Ltd.; Ono Pharmaceutical Co., Ltd.; Tsumura & Co.; Kyouwa Hakkou Kirin Co., Ltd.; EA Pharma Co., Ltd.; Medicon Inc.; Kaken Pharmaceutical Co. Ltd.; Eisai Co., Ltd.; Otsuka Pharmaceutical Factory Inc.; Teijin Pharma Limited; Nihon Pharmaceutical Co., Ltd.; Nippon Covidien Inc.; Shionogi & Co., Ltd.; Ethicon, Inc.; Olympus Corporation Bristol-Myers Squibb; K.K. AstraZeneca K.K. MSD K.K. Smith & Nephew KK ASKA Pharmaceutical Co., Ltd.; Miyarisan Pharmaceutical Co. Ltd.
